News

Statins may increase risk diabetes risk: study
Friday, May 24, 2013 Some cholesterol-lowering drugs may put patients at an increased risk of developing type-2 diabetes, according to a new...

Scientists step closer to developing universal influenza jab
Thursday, May 23, 2013 Scientists in the US have edged a step closer to developing a universal vaccine that would protect against multiple strains of influenza without the need for an annual seasonal flu...

Boehringer responds to FDA warning letter
Thursday, May 23, 2013 Boehringer-Ingelheim has responded to a warning letter issued by the US Food and Drug Administration that faults the company for not correcting “significant violations” of good...

Actavis to acquire Warner Chilcott in $8.5bn deal
Wednesday, May 22, 2013 US drug maker Actavis has struck a $5bn deal to acquire Ireland’s Warner Chilcott as it looks to fend off takeover...

Alzheimer’s drug trial coincides with UK’s Dementia Awareness week
Wednesday, May 22, 2013 TauRx Therapeutics has announced that the first of over 100 UK patients have enrolled in the global Phase III clinical trials of its experimental Alzheimer’s drug...

Ranbaxy Laboratories gets tentative approval for HIV combination therapy
Tuesday, May 21, 2013 The US Food and Drug Administration has granted tentative approval for a fixed dose formulation of two generic drugs for use in combination with...

UK scientists hail brain disease breakthrough
Tuesday, May 21, 2013 Scientists in the UK have mapped a pathway that generates “aberrant” forms of proteins at the root of degenerative diseases such as Alzheimer’s and...

Bayer acquires herbal medicines manufacturer
Monday, May 20, 2013 Bayer Pharmaceuticals has struck a deal to acquire Germany’s Steigerwald Arzneimittelwerk, a privately held company specialising in herbal...

Elan strikes two more drug deals to fend off Royalty Pharma bid
Monday, May 20, 2013 Irish pharmaceutical company Elan has agreed to buy two private drug companies and plans to buy back more shares as it looks to fend off a takeover bid from US investment firm Royalty...

UK firm halts sale of convulsion drug to Arkansas over death row use
Friday, May 17, 2013 UK-based pharmaceutical company Hikma has stopped supplying convulsion drug phenobarbital to Arkansas in the US to prevent it being used in state...

FDA approves radiation prostate cancer drug
Friday, May 17, 2013 The US Food and Drug Administration has approved a new drug for the treatment of an advanced type of prostate cancer that spreads to the...

Roche releases positive results for first-of-its-kind leukaemia drug
Thursday, May 16, 2013 A Phase III study into the effectiveness of a first-of-its-kind targeted cancer antibody drug developed by Roche for patients with chronic lymphocytic leukaemia (CLL) and co-existing...

US human cloning breakthrough turns skin cells into embryos
Thursday, May 16, 2013 For the first time ever, scientists in the US have turned human skin cells into early-stage embryos, which were then used to create specialised tissue cells for transplant...

Human Rights Watch welcomes Ukraine’s palliative care breakthrough
Wednesday, May 15, 2013 The Human Rights Watch has welcomed Ukraine's approval of new regulations that will allow greater access to strong painkillers, such as...

Low-cost Rotavirus vaccine revealed by scientists in India
Wednesday, May 15, 2013 A new vaccine to prevent Rotavirus, which kills around half a million children a year, has been unveiled by scientists in...

Ranbaxy pays record fine in adulterated drugs case
Tuesday, May 14, 2013 Indian drug maker Ranbaxy Laboratories has agreed to pay a record fine to settle a criminal and civil lawsuit related to drug...

Eli Lilly Phase III lymphoma study fails to meet primary endpoint
Tuesday, May 14, 2013 Eli Lilly has announced that its Phase III clinical trial of enzastaurin for the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL) has failed, after results did not...

GSK wins approval for COPD drug
Monday, May 13, 2013 GlaxoSmithKline's Breo Ellipta for the treatment of chronic obstructive pulmonary disease (COPD) has been approved by the US Food and Drug...

Deadly coronavirus may be able to spread from person to person, say WHO
Monday, May 13, 2013 Current and previous cases suggest that the deadly novel coronavirus, which has killed 18 people, can be spread from person to person, the World Health Organisation (WHO) has said in a...

GSK and Save the Children partner to save one million lives
Friday, May 10, 2013 GlaxoSmithKline (GSK) and charity Save the Children have joined forces to run two flagship programmes aimed at saving the lives of some of the world's poorest...